MIAMI--(BUSINESS WIRE)--J&J Green Paper Inc., the visionary creator of JANUS®, an innovative compound and process for producing water-resistant paper and packaging free from toxic oil-based materials, has closed several transformative global agreements to enable large-scale production of this environmentally...
IPH6501 is a first-in-class tetra-specific antibody-based natural killer cell engager therapeutic, based on ANKET® platform, targeting CD20 developed for the treatment of B-cell non-Hodgkin's lymphomas
IPH6501 is progressing towards a Phase 1 clinical trial in 2023
MARSEILLE, France--(BUSINESS WIRE)--#ANKET--Innate Pharma SA...
GOLDEN, Colo.--(BUSINESS WIRE)--$AUMN #gold--Golden Minerals Company (“Golden Minerals”, “Golden” or the “Company”) (NYSE-A: AUMN and TSX: AUMN) today announced that on June 6, 2023, the Company was notified by the NYSE American LLC (the “NYSE American”) that it was...
TORONTO--(BUSINESS WIRE)--$MIMZF #gold--Nighthawk Gold Corp. (“Nighthawk” or the “Company”) (TSX: NHK; OTCQX: MIMZF) is pleased to announce the filing of a technical report for the preliminary economic assessment (“PEA”) for the Colomac Gold Project (the “Project”), with an effective...
OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® Inc. (“Kinaxis” or the “Company”) (TSX:KXS), the authority in driving agility for fast, confident decision-making in an unpredictable world, received approval for all resolutions put forward to shareholders at today’s Annual General Meeting of Shareholders (the...
TORONTO--(BUSINESS WIRE)--$ELBM--Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced that Craig Cunningham has resigned from his position as Chief Financial Officer. Mr. Cunningham will provide a smooth transition through his resignation date, June...
-- WU-CART-007 was well-tolerated in patients with R/R T-ALL/LBL, with low incidence of high-grade CRS and immune-related adverse events --
-- WU-CART-007 demonstrated preliminary evidence of anti-leukemic activity; achieved 57% overall response rate (ORR) at Dose Levels (DL) 2 and...
Interim Analysis from Phase 2 Trial Demonstrates Compelling Anti-Tumor Activity in Patients with Frontline and Relapsed/Refractory BPDCN; No New Safety Signals Identified
Enrollment Continues in Frontline CADENZA Cohort; Top-Line Pivotal Data Expected in 2024WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Inc. (Nasdaq: IMGN), a...
Sends anniversary message of gratitude “from Osaka, to the world”OSAKA, Japan--(BUSINESS WIRE)--#Capcom--Capcom Co., Ltd. (TOKYO:9697) will celebrate its 40th anniversary on June 11, 2023, as the date marks forty years since the company’s founding on June 11, 1983. In...
AMSTERDAM & SANTA CLARA, Calif.--(BUSINESS WIRE)--Archer Aviation Inc. (NYSE: ACHR) and Stellantis N.V. will attend the 54th edition of the 2023 Paris Air Show, starting June 19, 2023, to share progress toward scaling manufacturing of Archer’s Midnight eVTOL aircraft...